Amicus Therapeutics (FOLD) Posts Positive Update from Migalastat HCl Phase 3 in Fabry
Tweet Send to a Friend
Amicus Therapeutics (Nasdaq: FOLD) announced positive 18-month data from its second Phase 3 study (Study 012) of the oral small ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
